|
|
| Line 25: |
Line 25: |
| <span style="display:none">availableVariable::cancer incidence|Cancers</span> | | <span style="display:none">availableVariable::cancer incidence|Cancers</span> |
| <span style="display:none">dataLevel::national level</span> | | <span style="display:none">dataLevel::national level</span> |
| | <span style="display:none">isReport</span> |
| <span style="display:none">hasCancerType::C50: Breast cancer</span> | | <span style="display:none">hasCancerType::C50: Breast cancer</span> |
| <span style="display:none">isReport</span>
| |
| <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
| |
| <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
| |
| <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
| |
| <span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
| |
| <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
| |
| <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
| |
| <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
| |
| <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
| |
| <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
| |
| <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
| |
| <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
| |
| <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
| |
| <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
| |
| <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
| |
| <span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
| |
| <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
| |
| <span style="display:none">hasCancerType::unknown</span>
| |
forpolicymakers
sloveniacountry
Go back to Slovenia page
Primary purpose: The early detection of breast cancer among women aged 50 to 69 in Slovenia, aiming to reduce breast cancer mortality by 25 to 30 percent through regular screening mammography and informed participation.
Sponsor, manager or home institution: Ljubljana Oncology Institute; DORA Program.
Type of information: Coverage and participation of the DORA Program; Number of breast screenings; Cancers detected in the screening program. Click here to learn more.
Data level: national level.
Cancer areas of interest: C50: Breast cancer. Click here to learn more.
Access to information: To access annual reports, go to DORA program reports, click here to access.
Lobular
Breast
Nipple
Areola
Ductal
dataOwner::Ljubljana Oncology Institute
dataOwner::DORA Program
availableVariable::screening
availableVariable::cancer incidence|Cancers
dataLevel::national level
isReport
hasCancerType::C50: Breast cancer
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
